The SARS-COV-2 enters the cytoplasm through ACE2 and AXL-mediated endocytosis, which may cause the decrease in serum ACE2 and AXL levels in the initial cohort of COVID-19 patients. This evidence concerns the gene ACE2 and COVID-19.